LFCR Earnings LIFECORE BIOMEDICAL, INC. \DE\
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | -0.19 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.43 | 2026-05-06 | 10-Q |
| Q1 2026 | 2025-09-30 | -0.29 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-05-25 | -0.06 | — | — |
| FY 2025 | 2025-05-25 | -1.27 | 2025-08-07 | 10-K |
| Q3 2025 | 2025-02-23 | -0.42 | 2025-04-03 | 10-Q |
| Q2 2025 | 2024-11-24 | -0.25 | 2025-01-02 | 10-Q |
| Q1 2025 | 2024-08-25 | -0.53 | 2024-10-04 | 10-Q |
| Q4 2024 (derived) | 2024-05-26 | -0.13 | 2024-08-26 | 10-K |
| FY 2024 | 2024-05-26 | 0.33 | 2024-08-26 | 10-K |
| Q3 2024 | 2024-02-25 | 0.42 | 2024-08-09 | 10-Q |
| Q2 2024 | 2023-11-26 | 0.39 | 2024-08-09 | 10-Q |
| Q1 2024 | 2023-08-27 | -0.35 | 2024-08-09 | 10-Q |
| Q4 2023 | 2023-05-28 | -1.32 | 2024-03-20 | 10-K |
| FY 2023 | 2023-05-28 | -3.32 | 2024-03-20 | 10-K |
| Q3 2023 | 2023-02-26 | -1.20 | 2023-06-02 | 10-Q |
| Q2 2023 | 2022-11-27 | -0.43 | 2023-03-16 | 10-Q |
| Q3 2022 | 2022-08-28 | -0.37 | 2022-10-07 | 10-Q |
| Q4 2022 | 2022-05-29 | -1.88 | — | — |
| FY 2022 | 2022-05-29 | -3.97 | 2022-09-14 | 10-K |
| Q3 2022 | 2022-02-27 | -0.46 | 2022-04-07 | 10-Q |
| Q2 2022 | 2021-11-28 | -1.31 | 2022-01-07 | 10-Q |
| Q1 2022 | 2021-08-29 | -0.32 | 2021-10-05 | 10-Q |
| Q4 2021 (derived) | 2021-05-30 | -0.04 | 2021-07-29 | 10-K |
| FY 2021 | 2021-05-30 | -1.10 | 2021-07-29 | 10-K |
| Q3 2021 | 2021-02-28 | -0.24 | 2021-04-08 | 10-Q |
| Q2 2021 | 2020-11-29 | -0.40 | 2021-01-07 | 10-Q |
| Q1 2021 | 2020-08-30 | -0.42 | 2020-10-07 | 10-Q |
| Q4 2020 (derived) | 2020-05-31 | -0.53 | 2020-08-14 | 10-K |
| FY 2020 | 2020-05-31 | -1.31 | 2020-08-14 | 10-K |
| Q3 2020 | 2020-02-23 | -0.39 | 2020-04-03 | 10-Q |
| Q2 2020 | 2019-11-24 | -0.23 | 2020-01-02 | 10-Q |
| Q1 2020 | 2019-08-25 | -0.16 | 2019-10-03 | 10-Q |
| Q4 2019 (derived) | 2019-05-26 | -0.02 | 2019-08-01 | 10-K |
| FY 2019 | 2019-05-26 | 0.01 | 2019-08-01 | 10-K |
| Q3 2019 | 2019-02-24 | 0.04 | 2019-04-04 | 10-Q |
| Q2 2019 | 2018-11-25 | -0.02 | 2019-01-07 | 10-Q |
| Q1 2019 | 2018-08-26 | 0.01 | 2018-10-05 | 10-Q |
| Q4 2018 (derived) | 2018-05-27 | 0.22 | 2018-08-09 | 10-K |
| FY 2018 | 2018-05-27 | 0.89 | 2018-08-09 | 10-K |
| Q3 2018 | 2018-02-25 | 0.57 | 2018-04-05 | 10-Q |
| Q2 2018 | 2017-11-26 | 0.02 | 2018-01-05 | 10-Q |
| Q1 2018 | 2017-08-27 | 0.08 | 2017-09-28 | 10-Q |
| Q4 2017 | 2017-05-28 | 0.09 | 2017-08-11 | 10-K |
| FY 2017 | 2017-05-28 | 0.38 | 2017-08-11 | 10-K |
| Q3 2017 | 2017-02-26 | 0.13 | 2017-04-07 | 10-Q |
| Q2 2017 | 2016-11-27 | 0.05 | 2017-01-05 | 10-Q |
| Q1 2017 | 2016-08-28 | 0.12 | 2016-09-29 | 10-Q |
| Q4 2016 | 2016-05-29 | 0.17 | 2016-08-01 | 10-K |
| FY 2016 | 2016-05-29 | -0.43 | 2016-08-01 | 10-K |
| Q3 2016 | 2016-02-28 | -0.78 | 2016-03-30 | 10-Q |
| Q2 2016 | 2015-11-29 | 0.07 | 2016-01-07 | 10-Q |
| Q1 2016 | 2015-08-30 | 0.11 | 2015-10-01 | 10-Q |
| Q4 2015 | 2015-05-31 | 0.15 | 2015-07-31 | 10-K |
| FY 2015 | 2015-05-31 | 0.50 | 2015-07-31 | 10-K |
| Q3 2015 | 2015-03-01 | 0.14 | 2015-04-02 | 10-Q |
| Q2 2015 | 2014-11-30 | 0.12 | 2015-01-09 | 10-Q |
| Q1 2015 | 2014-08-31 | 0.09 | 2014-10-08 | 10-Q |
| Q4 2014 | 2014-05-25 | 0.17 | 2014-08-01 | 10-K |
| FY 2014 | 2014-05-25 | 0.71 | 2014-08-01 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.